Biocitech, December 10th 2007 - Cellectis S.A., the genome engineering company developing a new range of custom DNA rewriting products for the healthcare, research and industrial sectors, today announced two significant nominations. Professor Alain Fischer will join the company's Scientific Advisory Board, whilst Alain Godard (a former President of the Executive Board at Aventis CropSciences) joins the Cellectis Board of Directors as an independent member.
